rose to 89.9% from 86.6% in the prior year period, and the company’s per-share earnings on a non-GAAP basis fell ~47% YoY to $4.16. However, Humana (HUM) reiterated its insurance segment’s ...

Actions taken by Humana to weather tumult in the Medicare Advantage program appear to be bearing fruit. On Wednesday, the insurer reported better-than-anticipated third quarter results and ...

Humana provides three types of Medicare coverage options for Medicare users. Its Medigap plans are designed to help seniors afford the cost of healthcare by covering items not traditionally ...

LAS VEGAS — Blue Shield of California and Salesforce, a cloud-based customer relation management company, announced a partnership on Monday that aims to cut down the prior authorization process ...

Oct 18 (Reuters) - U.S. health insurer Cigna Group (CI.N), opens new tab has revived efforts to merge with smaller rival Humana (HUM.N), opens new tab after abandoning the pursuit late last year ...

If Cigna and Humana were to come together, they would form a company that could potentially rival industry giants UnitedHealth Group and CVS Health. However, the feds have made it clear that they ...

The subcommittee found that, between 2019 and 2022, UnitedHealthcare, Humana, and CVS each denied prior authorization requests for post-acute care “at far higher rates than they did for other ...

As AI is rapidly proliferating in healthcare, California and Oklahoma are among the first states that have passed legislation governing the use of AI in prior authorization decisions. Other states ...

The subcommittee sought documents and information from the three largest MA insurance companies — UnitedHealthcare, Humana and CVS — and investigated their practice of “intentionally using prior ...

and said the panel failed to take into account Humana's response pointing out errors. The report acknowledged that regulators collect data on Medicare Advantage plans' use of prior authorization ...

It outlines attempts from UnitedHealthcare, CVS and Humana—which collectively cover nearly 60% of all MA enrollees—to use technology to reject prior authorization claims, all while reaping profit.